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A B S T R A C T
Background
Dementia and severe cognitive impairment are very closely linked to ageing. The longer we
live the more likely we are to suffer from these conditions. Given population increases in
longevity it is important to understand not only risk and protective factors for dementia and
severe cognitive impairment at given ages but also whether protection affects cumulative risk.
This can be explored by examining the effect on cumulative risk by time of death of factors
found consistently to reduce risk at particular ages, such as education and social status.
Methods and Findings
In this analysis we report the prevalence of dementia and severe cognitive impairment in the
year before death in a large population sample. In the Medical Research Council Cognitive
Function and Ageing Study (a 10-y population-based cohort study of individuals 65 and over in
England and Wales), these prevalences have been estimated by age, sex, social class, and
education. Differences have been explored using logistic regression. The overall prevalence of
dementia at death was 30%. There was a strong increasing trend for dementia with age from
6% for those aged 65–69 y at time of death to 58% for those aged 95 y and above at time of
death. Higher prevalences were seen for severe cognitive impairment, with similar patterns.
People with higher education and social class had significantly reduced dementia and severe
cognitive impairment before death, but the absolute difference was small (under 10%).
Conclusions
Reducing risk for dementia at a given age will lead to further extension of life, thus
cumulative risk (even in populations at lower risk for given ages) remains high. Ageing of
populations is likely to result in an increase in the number of people dying with dementia and
severe cognitive impairment even in the presence of preventative programmes. Policy
development and research for dementia must address the needs of individuals who will
continue to experience these conditions before death.
The Editors’ Summary of this article follows the references.
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Introduction
Changing global population structures require societies to
face major issues raised by increasing numbers of the very
old. Western societies have experienced sufficient change to
be able to anticipate patterns of health and ill health in their
ageing populations. These changes are likely to be echoed in a
shorter time frame over the next decades in the less wealthy
regions of the world because of their more rapid experience
of demographic shift. This continuing change in life expect-
ancy has been attributed to improved health and lower
morbidity in early life, and to effective primary, secondary,
and tertiary prevention in later life. Reductions in incidence
have been seen in vascular disease, including cerebrovascular
disease [1,2].
Increased life expectancy and improvement in many areas
of health have been demonstrated, but sharp increases of
morbidity with age are still observed in all populations [3].
Dementia and severe cognitive impairment are amongst the
disorders with greatest increase with age in both incidence
and prevalence [4,5]. Preventive action at the population level
ideally eradicates risk of disease, but in reality much
prevention reduces disease at a given age rather than
eradicating its occurrence. The overall contribution of
primary and secondary prevention to the reduction in
cardiovascular disease mortality has been estimated at
around half of the effect, with improved care for established
disease resulting in the remaining improvement [6]. There is
a global effort aimed at improving health in our older
populations, and much of this effort hinges on the hope that
extension of life expectancy will not be accompanied by
increases in morbidity but by compression of morbidity [7].
Many of the factors that have been observed to be
associated with reduced risk for chronic disease such as
cancer and heart disease are also associated with lower
mortality [8–10]. More recently such factors have also been
studied in relation to Alzheimer disease and cerebrovascular
disease and have been reported as associated with reduction
in risk within the periods of follow-up [11]. These variables
are often associated with social class and educational level,
whose effects may be attributed to healthier lifestyles and
health practices. Social class and education can be seen as
proxies for these factors, and higher social class and more
education have been shown in many studies to be associated
with reduction in dementia outcomes [12,13].
At the same time as this attention to healthy ageing there is
increasing attention to the end of life. Many people express a
fear of dementia before death as well as a desire to remain
independent up to the time of death rather than have
prolonged periods of dependency. Quality of life in the
period leading up to death is a relatively neglected area in the
major emphases of most countries’ health services, which
tend, understandably, to focus on prevention and treatment.
There is already clear evidence that individuals who have
dementia and cognitive impairment have an excess mortality
[14] and a shorter life expectancy [15] than individuals
without. However, there is little information about the
proportion of the population at any given age who die with
dementia or severe cognitive impairment. Individuals at the
end of life are likely to be underrepresented in studies of risk
with infrequent follow-up as attrition is well known to be
associated with cognitive decline and age [16]. Information on
the dementia status of individuals from death certificates is
inaccurate and cannot be used as a substitute [17]. More
knowledge about the status of individuals in the period
before and at death is important to assess the full
implications of global population ageing and the potential
for prevention of dementia and cognitive decline in the
future. If we change risk in the population, can we expect to
see different profiles in our very old population, including
the period close to death? What is the association of dementia
and cognitive decline with death (terminal decline), and how
much can we estimate that we would avoid if all the
preventive actions in place were able to effect a reduction
in health inequalities? Longitudinal studies with sufficient
follow-up and data on the mortality of all individuals are
required to investigate dementia at death. Repeated inter-
views are necessary to correctly classify dementia at death.
Notification of death for the whole cohort irrespective of
continuing participation is also required.
The analysis presented in this paper investigates the
prevalence of dementia and severe cognitive impairment in
the period before death in the population-based Medical
Research Council Cognitive Function and Ageing Study
(MRC CFAS). It also investigates whether those who, on the
basis of the literature to date, would be expected to have a
relative advantage in risk for dementia at any given age are
markedly less likely to die with dementia or severe cognitive
impairment than those at greater risk.
Methods
Study Design and Population
MRC CFAS is a longitudinal population-based cohort study
that involves six different study centres. The six centres were
chosen because they represent the main national variation
with regards to urban–rural differences, the north–south and
east–west gradients, and variation in socio-economic levels
and in known rates of chronic disease. All centres had
existing researchers who were interested in population-based
studies of the elderly. Urban sites included Liverpool,
Newcastle, Nottingham, and Oxford. Rural sites included
Cambridgeshire and Gwynedd, in North Wales. All centres
have been used for this analysis.
The Liverpool study is described in full elsewhere [18]; a
population stratified by 5-y bands over the age of 65 y was
interviewed from 1989 onwards. Three full waves of follow-up
(each 2 y apart) have been undertaken and used in the
following analysis.
The full study design of the other five centres is described
in detail elsewhere and is explained briefly here [4]. For these
five centres, a total of 13,004 individuals aged 65 y and over
were recruited, and interviewed at baseline (1990–1992) with
a schedule including socio-demographic items, general health
items, and cognitive items. Participants have been re-
interviewed at various times, either the whole cohort or
sub-samples stratified by centre, age, and cognitive state.
Three types of interviews were used during the study.
Baseline examination was conducted via a screening inter-
view. A median of 3 mo after a screening interview, 20% of
individuals had a diagnostic interview (assessment interview).
The assessment interview consisted of a participant interview
and an informant interview. The former consisted of the
Geriatric Mental State (GMS), version B3, from which
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AGECAT [19] could be derived. The latter consisted of the
History and Aetiology Schedule [20]. These are standardised
psychiatrically based interviews to establish an algorithmic
clinic diagnosis described below. Incidence screen and
assessments and combined screen and assessment interviews
were used during the follow-ups at 2 y, and combined screen
and assessment interviews on all participants at 10 y. All
interviews contained the Mini-Mental State Examination
(MMSE). The Cambridge centre additionally interviewed the
complete sample with a combined screen and assessment
interview at 6 y. In Liverpool the whole population was
interviewed with the full GMS AGECAT algorithm and the
clinical version of the MMSE [21] on all these occasions. A
study diagnosis of dementia and cognitive impairment can be
derived from successful interviews.
All participants were flagged for mortality information.
Death information was obtained from the Office of National
Statistics up to the end of 2004. Version 8.0 of the five-centre
identical data and version c4 for the Liverpool data have been
used.
Definition of Dementia
The study diagnosis of dementia is based on the GMS
AGECAT algorithm. This algorithm has been validated
against clinicians and DSM-III-R [22]. In addition, for the
analysis presented here, organicity level and memory defect
rating at the last available interview before death were
combined with ICD-10 diagnosis [23] (F00–F03, F29, F051, or
G30) on the death certificate. Misclassification with organ-
icity due to transient delirium is rare in the population
studies [4].
Definition of Cognitive Impairment
MMSE scores were coded within each centre using identical
methodology (ignoring backwards WORLD and coding ‘‘not
answered’’ responses to incorrect). Some differences existed
between the implementation of the questions (for example,
apple, table, and penny in the five identical centres was any
three items in Liverpool); however, examination of the
distribution of the scores indicates that they have similar
distributional properties at the lower end. The scores were
grouped into severe cognitive impairment (MMSE , 18) or
not, and moderate/severe cognitive impairment (MMSE ,
22). Where the MMSE was missing at the last interview before
death, a previous interview was used if cognitive impairment
had already been demonstrated. In the analysis presenting
cognitive impairment, the classification of dementia status on
death certificates was ignored. Individuals with cognitive
impairment were classified only from interview responses,
and hence some individuals with dementia on death
certificates were not classified as cognitively impaired.
Interview Waves
Only study waves where the complete population was
interviewed were used in this analysis. Hence, information for
Liverpool years 0, 2, and 4 and for the other five centres years
0, 2, 6 (Cambridge only), and 10 were used.
The dementia or cognitive impairment status required is
the status at death for an individual, hence only those
individuals whose last interview was within 1 y of their death
were considered. A sensitivity analysis expanding this to
deaths within 2 y has been undertaken, which is based on
more deaths, but which underestimates the true amount of
dementia/cognitive impairment.
Statistical Methods
Prevalence of dementia at death was calculated assuming
binomial proportions with exact confidence intervals (CIs).
Logistic regression analysis was used to investigate the
relationships between confounders and prevalence of de-
mentia at death. All analysis was undertaken using STATA
version 8.0 (Stata Corporation, College Station, Texas, United
States).
Results
Deaths
A total of 4,319 individuals from Liverpool (from an
original sample 5,244) and 8,068 individuals from the other
centres (from 13,004)—altogether 12,387 individuals—died by
the time of this analysis. Of these, 12,286 deaths (99%) have
information available from their death certificate. A total of
2,566 individuals who had a known dementia status at last
interview died within 1 y of this interview, and 5,053 died
within 2 y of this interview. A total of 2,555 individuals are
included in the analysis of severe cognitive impairment, and
2,573 individuals in the analysis of moderate/severe cognitive
impairment.
Dementia at Death
Table 1 shows a summary of dementia status at death
classified by centre, sex, social class, education level, and age
at death. Figure 1 shows a sustained increase in the
proportion of individuals receiving a study diagnosis of
dementia in the period before death with increased age at
death (log). People who died between the ages of 65 and 69 y
had a 6% risk of dying with dementia, but people who died
above age 95 y had an over 58% risk of dying with dementia.
There are wide confidence intervals around the estimate for
the 31 individuals aged over 100 y at death, compatible with
continued increase and stabilisation (42% demented, 95% CI
25%–61%).
There was a gender difference in risk, with women
demonstrating an overall prevalence of dementia before
death of 38%, almost double that of men. However, women
have a longer life expectancy than men [24], and dementia
prevalence increase with age [4]. Adjusting for age showed
that women still had a higher absolute proportion of
individuals with dementia than men (Table 1; Figure 2);
however, there was no evidence that the effect of age differed
in men and women (likelihood ratio test for interaction, v2¼
7.6, p¼ 0.27). Dementia before death was less common in the
non-manual-labour social classes than in the manual-labour
group at all ages, but not after adjusting for other factors (p¼
0.09) (Table 1; Figure 2). The absolute difference at death was
2%. A higher level of education was associated with slightly
lower prevalence of dementia before death, even after
adjusting for the other factors (p ¼ 0.02) (Table 1; Figure 2).
The individuals who had 10 y or more of full-time education
had slightly lower dementia prevalence than individuals with
less than 10 y of full-time education. The absolute difference
between these educational levels was 6%. There was no
evidence of any interaction between sex, education, and
social class (likelihood ratio tests all had p . 0.2). An
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individual analysis investigated whether the age effect was
partially explained by different patterns of dementia seen in
different birth cohorts. There was no evidence that suggested
there has been a change in the age and sex pattern by birth
cohort after adjusting for all other covariates (likelihood ratio
test, p . 0.2).
Those participants who had an unknown social class and/or
educational level (378, 15%) were more likely to have been
demented at both baseline and follow-up (62% demented). A
sensitivity analysis including these missing values as either the
highest or lowest categories did not alter the findings.
Cognitive Impairment
The proportion of individuals with severe cognitive
impairment before death was very similar to the proportion
of individuals with dementia at death, with the same marked
increase in cognitive impairment before death with age
(Figure 1; Table 2). When individuals with moderate or severe
cognitive impairment were included together, the rate was
around 10% higher at all ages, with nearly 80% of individuals
dying over 95 y of age having this level of cognitive
impairment.
The relationship between cognitive impairment and
demographic risk factors was almost identical between the
less and more inclusive levels of impairment and similar to
the relationships with dementia at death, though the effects
were all slightly stronger. The patterns were also similar if
individuals with dementia were removed from the analysis
(unpublished data). The absolute difference in severe
cognitive impairment at death between social class groups
was 5% and for educational levels was 7%. The absolute
differences for moderate/severe cognitive impairment were
7% and 10%, respectively.
Centenarians
There were 31 centenarians in the study who died within 1
y of interview. Of these, 25 (81%) were female, 13 (42%) had
dementia, and 13 (46%) had severe cognitive impairment
(with three missing information).
Centre Effects
Although not the primary purpose of this analysis, centre
was included as it may indicate unmeasured confounders. For
dementia there were no differences between the centres once
age and sex were accounted for. There were some small
differences between centres for cognition before death, but
no consistent pattern emerged.
Sensitivity Analysis
Including all individuals with an interview within 2 y of
death did lower the proportions of individuals with dementia
before death slightly (27% versus 30%). The proportion with
dementia within 1 y of death (30%) was higher than that
estimated for individuals seen between 1 and 2 y before death
(23%; t-test for difference, p , 0.001), showing the proximity
of much dementia to death. The findings in relation to age,
sex, social class, and education were similar. Excluding
individuals with limited information (such as screen-only
data) did not indicate introduction of bias.
Population Impact
These results were combined with population projections
for mortality. The number of deaths per year by age for
England and Wales and the US [25,26] was combined with the
prevalence of dementia at death. The prevalence rate of
dementia was assumed to stay constant with time as there has
been no apparent change with each successive 5-y birth
cohort studied (year of birth ranges from 1888 to 1928). The
Table 1. Prevalence of Dementia at Death and Relationship to Potential Risk Factors for All Individuals Who Died within 1 y of Last
Interview
Variable Level Not Demented (%) Demented (%) Logistic Regression Odds Ratioa (95% CI)
Centre Cambridge 251 (74) 90 (26)
Gwynedd 205 (68) 97 (32)
Liverpool 728 (69) 323 (31)
Newcastle 207 (73) 77 (27)
Nottingham 196 (67) 98 (33)
Oxford 211 (72) 83 (28)
Age 65–69 102 (94) 7 (6) 1.0
70–74 231 (90) 27 (10) 1.8 (0.7–4.9)
75–79 338 (85) 62 (16) 2.7 (1.1–7.1)
80–84 442 (76) 140 (24) 4.2 (1.6–10.5)
85–89 368 (61) 239 (39) 9.6 (3.8–24.2)
90–94 241 (56) 187 (44) 10.4 (4.1–26.3)
95þ 76 (42) 106 (58) 19.2 (7.3–50.5)
Sex Male 966 (78) 267 (22) 1.0
Female 832 (62) 501 (38) 1.5 (1.2–1.8)
Social Class Non-manual labour 861 (76) 271 (24) 0.8 (0.7–1.0)
Manual labour 801 (74) 284 (26) 1.0
Missing 136 (39) 213 (61)
Education ,10 y 1,272 (71) 510 (29) 1.0
10 y 495 (77) 145 (23) 0.8 (0.6–1.0)
Missing 31 (22) 113 (78)
Total 1,798 (70) 768 (30)
aModel for individuals with complete data adjusted for all other factors in the table (excluding centre and individuals with missing data).
DOI: 10.1371/journal.pmed.0030397.t001
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results indicate that currently there are 114,000 individuals
(95% CI 97,000–134,000) in England and Wales and 487,000
individuals (95% CI 362,000–503,000) in US who die with
dementia each year. In 20 years’ time, these numbers will have
increased to 138,000 (95% CI 118,000–160,000) in England
and Wales and 528,000 (95% CI 443,000–627,000) in the US.
Discussion
Summary of Findings
This 10-y longitudinal population study of people aged 65 y
and over at baseline examines dementia and severe cognitive
impairment status in the period before death and shows that
the prevalence of dementia and severe cognitive impairment
in the period before death rises steeply with age. Thus, by the
time an individual aged 90 y dies, the risk of being demented
or severely cognitively impaired is around 60%. Investigating
whether higher education and social class—proxies for
healthy exposures and lifestyles—protected individuals from
dementia by the time they died showed that individuals with
higher education and social class were at significantly
reduced risk of dying with dementia or cognitive impairment.
However, this reduction was limited: the reduction in
dementia had an absolute value of only 2% and 7%,
respectively, for higher social class and more highly educated
groups; the reduction in cognitive impairment was 7% and
10%, respectively; and both high education and social class
together conferred a reduction of 7% for dementia and 10%
for cognitive impairment. Thus, the inequalities in healthy
lifestyles and social advantage observed at given ages appear
to be attenuated by the longer life expectancy of those
individuals.
Critique of Findings
There are features of the study that need to be taken into
account in interpreting the findings. The response rate at
baseline and at each of the follow-up interviews was around
80% (see http://www-cfas.medschl.cam.ac.uk for details of
audit trail). Some bias could be introduced into the analysis
through this drop out due to death, refusal, and moving away.
We know from earlier analysis of the dataset that individuals
with cognitive impairment are at greater risk of death, so
there is some potential to underestimate the prevalence of
dementia at death given that we do not have cognitive status
close to death in all respondents. We have taken this into
account through the analysis of only those individuals who
died within a relatively short period of being interviewed. If
the analysis is conducted on the total sample for whom the
last interview was more distant from death, a lower
prevalence of dementia and cognitive impairment is found,
as expected. However, individuals who dropped out from the
study in the year preceding death were no more likely to be
demented than those who undertook an interview in this
time, indicating that the individuals analysed here are
unlikely to be biased.
The measure for dementia in this study was GMS diagnostic
algorithm organicity status, and for cognitive impairment was
MMSE. Both of these will suffer from some misclassification
bias. We have found severe MMSE and dementia states to be
relatively stable, with only small proportions moving out of
these categories in the extensive longitudinal data available.
Limiting the analysis to subtypes of dementia such as
Alzheimer disease or vascular dementia might indicate
preventive potential for specific subtypes by death but would
not reveal the true population picture, nor does cognitive
impairment and dementia in the oldest old tend to fit into
pure diagnostic categories [27]. Moreover, the concern many
older people express is not about specific forms of dementia
but that they will lose their independence and become
cognitively frail. We have not addressed the mildest stages of
impairment in this analysis.
Figure 1. Dementia or Cognitive Impairment by Age at Death with 95% CIs
DOI: 10.1371/journal.pmed.0030397.g001
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Figure 2. Rate of Dementia at Death by Sex, Education, and Social Class
DOI: 10.1371/journal.pmed.0030397.g002
PLoS Medicine | www.plosmedicine.org October 2006 | Volume 3 | Issue 10 | e3971927
Dementia before Death in Ageing Societies
Examining education and social class as proxies for healthy
lifestyles could be seen as a crude approach, but these have
been shown in their own right, in some studies, to be
independently associated with lower rates of dementia.
Certainly it would be desirable to expand this type of analysis
to population studies with better lifestyle and health
indicators—peak physical fitness, no smoking, moderate
alcohol, good nutrition, and no hypertension, diabetes, or
heart disease.
There are very few studies with which to compare these
findings. One US study examined patterns of change in
functional disability in the period before death [28]. Its goal
was more to examine the predictive value of such patterns. It
is already well established that cognitive impairment and
dementia are associated with increased risk of death. We set
out to examine how common dementia is by the time of death
and whether those groups who are held to be at reduced risk
of dementia and chronic disease during life appear to escape
the risk before death. We have found that this is not the case,
although there is a small diminution in risk before death,
consistent with the absolute risk reductions reported for
given ages in cohort studies. These findings confirm the
finding of an earlier study by Bickel, who conducted a
retrospective study of deaths by asking relatives about the
status of the deceased before death and reported a prevalence
of dementia-related conditions at death even higher than our
estimates [29]. Our data also agree with findings on the health
state of the very old, including centenarians. MRC CFAS
reports odds ratios of incidence of dementia of over 25 for
the 85-y-and-over age group compared to the 65- to 69-y age
group [30]. In a study of 34 centenarians by Silver and
colleagues [31], most (64%) were demented. Systematic
reviews have shown that prevalence of dementia at this age
is between 50% and 64% [32], with only 15%–25% estimated
to have functionally intact cognition [33,34].
Implications and Conclusions
These data have serious implications for societies that are
ageing. All public health services internationally will and
should continue to promote healthy ageing through healthy
lifestyles and optimal health care. It is important to continue
to research treatments and preventive approaches for specific
dementias aimed at lessening the devastation that dementia
and cognitive impairment can cause. Substantial claims have
been made for the prevention of dementia, and these need to
be backed up by robust evidence of risk reduction through
preventive strategies—not yet available as the evidence is
based on observational studies. However, our findings suggest
that preventive efforts are unlikely to be able to counteract
the profound effects of age and proximity to death
altogether. We will continue to examine early risk and track
cognitive change, but the analysis presented here is about
quality of life at the end of life. It may be that, although there
will be a preventable component to dementia giving us a
small and important absolute reduction in expectation of
dementia at given ages, there is also a component that is not
amenable to such types of prevention [35]. Researchers may
be doing those who are ageing now and themselves a
disservice in the future if they assume, and project to the
public, that dementia and cognitive impairment can be
prevented altogether during increasingly long lives. Given
Table 2. Prevalence of Moderate and Severe Cognitive Impairment at Death and the Relationship with Potential Risk Factors
Variable Level Severe Cognitive Impairment Moderate/Severe Cognitive Impairment
Total
Sample
Size
Number with
Impairment (%)
ORa (95% CI) Total
Sample
Size
Number with
Impairment (%)
ORa (95% CI)
Centre Cambridge 323 84 (26) 325 137 (42)
Gwynedd 329 115 (35) 330 163 (49)
Liverpool 997 276 (28) 1,001 414 (41)
Newcastle 311 77 (25) 314 128 (41)
Nottingham 305 103 (34) 308 150 (49)
Oxford 293 90 (31) 299 135 (45)
Age 65–69 109 5 (5) 1.0 109 14 (13) 1.0
70–74 268 33 (12) 3.7 (1.1–12.5) 269 58 (22) 2.1 (1.0–4.2)
75–79 407 53 (13) 3.7 (1.1–12.4) 408 96 (24) 2.1 (1.1–4.2)
80–84 573 129 (23) 6.5 (2.0–20.9) 573 204 (36) 3.8 (2.0–7.4)
85–89 615 230 (37) 15.0 (4.7–48.0) 620 334 (54) 8.0 (4.2–15.4)
90–94 416 191 (46) 20.2 (6.3–65.4) 425 285 (67) 13.6 (6.9–26.6)
95þ 170 104 (61) 38.2 (11.4–127.8) 173 136 (79) 22.8 (10.8–48.2)
Sex Male 1,244 251 (20) 1.0 1,249 419 (34) 1.0
Female 1,314 494 (38) 1.7 (1.4–2.1) 1,328 708 (53) 1.7 (1.4–2.0)
Social Class Non-manual labour 1,175 298 (25) 0.7 (0.6–0.9) 1,127 488 (43) 0.7 (0.5–0.8)
Manual labour 1,119 298 (27) 1.0 1,128 405 (36) 1.0
Missing 264 149 (56) 322 234 (73)
Education ,10 y 1,807 512 (28) 1.0 1,821 804 (44) 1.0
10 y 648 137 (21) 0.7 (0.6–0.9) 652 224 (34) 0.7 (0.5–0.8)
Missing 103 96 (93) 104 99 (95)
Total 2,558 745 (29) 2,577 1,127 (44)
aModel for individuals with complete data adjusted for all other factors in the table (excluding centre and individuals with missing data).
OR, odds ratio.
DOI: 10.1371/journal.pmed.0030397.t002
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that the population of all deaths accounted for by people
aged 85 y and over has increased from 8% in 1960 to 21% in
2003 in men and 16% to 41% in women in England and
Wales, this is a matter of considerable importance [36]. Our
data show that in the UK (and potentially in the US) the
burden of dementia and cognitive impairment at time of
death is substantial and is likely to become an increasing
problem as the population ages. It is essential and urgent that
societies invest in planning for (and researching) quality at
the end of life for those with dementia and severe cognitive
impairment [37–39], with sensible estimation of the likely
increase in the numbers affected in the decades to come.
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Editors’ Summary
Background. Severe cognitive impairment and its advanced form,
dementia, are among the most difficult problems associated with aging
in industrialized countries. Age-associated decline in mental functioning
is also expected to become more common in developing countries as
improvement of conditions that affect health leads to longer life
expectancies. Although the risk of cognitive impairment is known to
increase with age, the number of people who suffer from loss of mental
abilities in the last years of their lives has not been well studied, as such
persons are usually reported to have died from other causes. Further,
because the very elderly are seldom included in prevention studies, it is
not known whether factors found to reduce the risk of developing
dementia by a given age will provide protection until the end of life.
Why Was This Study Done? This study was designed to follow a
representative population of aged people over several years to estimate
the risk of developing cognitive impairment or dementia near the end of
life and to determine whether factors such as education and social class,
which may be protective earlier in life, can ultimately prevent decline in
mental functioning.
What Did the Researchers Do and Find? Using standardized assess-
ments of cognitive status, the researchers interviewed people age 65 and
over at six sites representing rural and urban areas in the United
Kingdom. Interviews were conducted at regular intervals over ten years.
Of approximately 12,000 study participants who had died by the time of
this report, just over 2,500 had an assessment for dementia within one
year before dying. Of this group, those who died between ages 65 and
69 had a 6% chance of dying with dementia, and those who died above
age 95 had a 58% chance of dying with dementia. When moderate and
severe cognitive impairment were considered together, the rate in
people above age 95 reached almost 80%. Women were more likely to
develop dementia than men, even after taking into account the fact that
women tend to live longer than men. A higher level of education was
associated with only a slightly lower risk of dementia before death.
What Do These Findings Mean? According to these results, as the
number of aged persons increases (with improved health care,
preventive medicine, and healthier lifestyles), the chances of developing
dementia in the last years of life will continue to increase. Factors
believed to protect against dementia at earlier times may be of little
effect at the end of life. Planning for aging societies must therefore
include not only research into treatments and preventive efforts to
reduce the impact of dementia at the end of life, but also realistic
allocation of resources to support individuals and their caregivers who
must deal with the difficulties of cognitive decline.
Additional Information. Please access these Web sites via the online
version of this summary at http://dx.doi.org/0030397.
 Web site of the Medical Research Council Cognitive Function and
Ageing Study
 Web site of the Alzheimer’s Association
 Wikipedia entry on dementia (note: Wikipedia is a free Internet
encyclopedia that anyone can edit)
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